LevitasBio is a biotechnology company that is developing a platform for the rapid and accurate detection of infectious diseases. The company's technology is based on magnetic levitation, which allows for the separation and detection of pathogens in a sample. LevitasBio's platform has the potential to revolutionize the way infectious diseases are diagnosed and treated, and could have a significant impact on global health. The company was founded in 2016 by Dr. Alex Jiao and Dr. Jesse Jokerst, and is headquartered in San Diego, California.